Skip to content

Trial Comparing Treatment With SInergy™ System to Conservative Treatment for Chronic Sacroiliac Joint Pain

A Randomized Controlled Trial Comparing Cooled Radiofrequency Denervation to Conservative Treatment as a Treatment for Sacroiliac Joint Pain Using the SInergy™ System

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01158092
Acronym
SI-RCT-Ross
Enrollment
5
Registered
2010-07-08
Start date
2010-07-31
Completion date
Unknown
Last updated
2013-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Sacroiliac Joint Pain

Brief summary

The purpose of this study is to evaluate the effectiveness of cooled radiofrequency denervation of the sacroiliac region using the SInergy System compared to conservative treatment in the treatment of sacroiliac joint pain.

Interventions

DEVICETreatment with SInergy™ System

Lateral branch denervation using the SInergy™ System

OTHERConservative Treatment

Treatment with physical therapy, chiropractic care, and medication

Sponsors

Baylis Medical Company
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Predominantly axial pain below the L5 vertebrae * \>75% pain relief from 2 separate lateral branch blocks done on different days (followed by return to baseline pain) * Chronic axial pain lasting for longer than six months: 3 day average VAS between 4 and 8. * Age greater than 18 years. * Failed to achieve adequate improvement with comprehensive non-operative treatments, including but not limited to: activity alteration, non-steroidal anti-inflammatory, physical and/or manual therapy, and fluoroscopically guided steroid injections in and around the area of pathology. * All other possible sources of low back pain have been ruled out, including but not limited to: the intervertebral discs, bone fracture, the zygapophyseal joints, the hip joint, symptomatic spondylolisthesis, tumor and other regional soft tissue structures (this is done by physical exam, medical history, and MRI/CT/X-ray as required)

Exclusion criteria

* Beck Depression Score \>20 or irreversible psychological barriers to recovery * Spinal pathology that may impede recovery such as spina bifida occulta, spondylolisthesis at L5/S1, or scoliosis. * Moderate or severe foraminal or central canal stenosis * Systemic infection or localized infection at anticipated introducer entry site. * Concomitant cervical or thoracic pain greater than 2/10 on a VAS * Uncontrolled or acute illness * Chronic severe conditions such as rheumatoid/inflammatory arthritis * Pregnancy * Active radicular pain * Immunosuppression (eg. AIDS, cancer, diabetes, surgery \<3 months ago) * Worker's compensation, injury litigation, or disability remuneration * Allergy to injectants or medications used in procedure * High narcotics use (\>30 mg hydrocodone or equivalent) * Patients who smoke. Termination for at least 6 months and no smoking during follow up period are acceptable with caution. * Body Mass Index greater than 29.9 (obese). * Subject unwilling to consent to the study

Design outcomes

Primary

MeasureTime frame
Pain status change for sacroiliac region pain intensity assessed using visual analogue scale (VAS)12 months

Secondary

MeasureTime frame
Change in bodily pain evaluated using SF-36 Bodily Pain12 months
Change in physical functioning evaluated using SF-36 Physical Function12 months
Change in disability evaluated using Oswestry Disability Index 2.012 months
Change in quality of life using the Assessment of Quality of Life (AQOL)12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026